Ftse Mib
34.216,82
0,68%
DAX
18.372,38
1,10%
S&P 500
5.187,83
0,14%
NASDAQ
16.373,81
0,15%
Bitcoin
63.213,06
0,07%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aduro Biotech Inc (ADRO) Aduro Biotech Inc (ADRO) Notizie

ADRO

Aduro Biotech (ADRO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADRO
DataOraFonteTitoloSimboloCompagnia
20/06/202315:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
20/06/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
12/06/202315:42Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADROAduro Biotech Inc
01/06/202301:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
09/05/202322:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADROAduro Biotech Inc
28/04/202323:43Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADROAduro Biotech Inc
17/04/202322:52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADROAduro Biotech Inc
12/04/202322:57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADROAduro Biotech Inc
10/03/202322:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADROAduro Biotech Inc
14/02/202322:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADROAduro Biotech Inc
10/11/202223:00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADROAduro Biotech Inc
10/11/202222:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADROAduro Biotech Inc
07/06/202222:46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADROAduro Biotech Inc
24/05/202222:01Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ADROAduro Biotech Inc
14/04/202222:46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADROAduro Biotech Inc
17/03/202221:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADROAduro Biotech Inc
03/03/202222:35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADROAduro Biotech Inc
09/11/202123:28Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ADROAduro Biotech Inc
15/04/202113:41Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADROAduro Biotech Inc
07/04/202122:55Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADROAduro Biotech Inc
30/03/202123:27Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ADROAduro Biotech Inc
05/11/202023:00Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADROAduro Biotech Inc
15/10/202023:17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADROAduro Biotech Inc
05/10/202015:00GlobeNewswire Inc.Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement FinancingNASDAQ:ADROAduro Biotech Inc
01/10/202022:05GlobeNewswire Inc.Aduro Biotech Stockholders Approve Merger Agreement with Chinook TherapeuticsNASDAQ:ADROAduro Biotech Inc
26/08/202022:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADROAduro Biotech Inc
24/08/202012:10Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ADROAduro Biotech Inc
18/08/202022:48Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ADROAduro Biotech Inc
03/08/202022:05GlobeNewswire Inc.Aduro Biotech Provides Business Update and Reports Second Quarter 2020 Financial ResultsNASDAQ:ADROAduro Biotech Inc
24/06/202014:15GlobeNewswire Inc.Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA NephropathyNASDAQ:ADROAduro Biotech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADRO

La tua Cronologia

BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
FBK
Finecobank
BIT
ENI
Eni
BIT
IRE
Iren
BIT
LDO
Leonardo
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
SRG
Snam
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network